Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Heart Failure: Telehealth during the pandemic | Pig heart transplant patient dies | AI models for RV & LV dysfunction
Friday, March 25, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Heart Failure

Telehealth provided value for heart failure patients during COVID-19 pandemic

Overall, researchers found, 30-day readmission was less common when heart failure patients used telehealth to check in with a physician after discharge. 

READ MORE >
A patient has a telehealth visit with their doctor remotely in their home via video conferencing. The COVID-19 cause massive movement to telehealth since 2020.
Share on Twitter Share on Facebook Share on Linkedin

Telehealth provided value for heart failure patients during COVID-19 pandemic

Share on Twitter Share on Facebook Share on Linkedin
A patient has a telehealth visit with their doctor remotely in their home via video conferencing. The COVID-19 cause massive movement to telehealth since 2020.
Overall, researchers found, 30-day readmission was less common when heart failure patients used telehealth to check in with a physician after discharge. 
READ MORE >

Pig heart transplant patient dies 2 months after historic procedure

The 57-year-old patient was able to communicate with his family in his final hours. 

READ MORE >
David Bennett
Share on Twitter Share on Facebook Share on Linkedin

Pig heart transplant patient dies 2 months after historic procedure

Share on Twitter Share on Facebook Share on Linkedin
David Bennett
The 57-year-old patient was able to communicate with his family in his final hours. 
READ MORE >

Cancer, cancer-related death much more common among heart failure patients

Researchers examined data from more than 208,000 patients, sharing their findings in JACC: CardioOncology. 

READ MORE >
lung cancer pulmonary nodule
Share on Twitter Share on Facebook Share on Linkedin

Cancer, cancer-related death much more common among heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
lung cancer pulmonary nodule
Researchers examined data from more than 208,000 patients, sharing their findings in JACC: CardioOncology. 
READ MORE >

COVID-19 vaccines safe for patients with a history of heart damage

“These results provide reassuring data that may encourage patients with a history of myocarditis to get vaccinated against SARS-CoV-2,” one specialist said. 

READ MORE >
There has been fear of a small number of patients who experience myocarditis after COVID vaccination, but a new study found it is safe in patients with prior heart damage. Image courtesy of Banner Health. #COVID19 #COVIDvaccination
Share on Twitter Share on Facebook Share on Linkedin

COVID-19 vaccines safe for patients with a history of heart damage

Share on Twitter Share on Facebook Share on Linkedin
There has been fear of a small number of patients who experience myocarditis after COVID vaccination, but a new study found it is safe in patients with prior heart damage. Image courtesy of Banner Health. #COVID19 #COVIDvaccination
“These results provide reassuring data that may encourage patients with a history of myocarditis to get vaccinated against SARS-CoV-2,” one specialist said. 
READ MORE >

PCI boosts survival for ischemic HF patients with moderate-to-severe mitral regurgitation

Mortality rates can be especially high for ischemic HF patients presenting with FMR and LVSD, but PCI may offer some relief. 

READ MORE >
PCI can improve the odds of survival for some ischemic heart failure patients with moderate-to-severe functional mitral regurgitation, according to a new study. Image courtesy of Beaumont Hospital. Interventional cardiology procedure in a cath lab at Beaumont Hospital.
Share on Twitter Share on Facebook Share on Linkedin

PCI boosts survival for ischemic HF patients with moderate-to-severe mitral regurgitation

Share on Twitter Share on Facebook Share on Linkedin
PCI can improve the odds of survival for some ischemic heart failure patients with moderate-to-severe functional mitral regurgitation, according to a new study. Image courtesy of Beaumont Hospital. Interventional cardiology procedure in a cath lab at Beaumont Hospital.
Mortality rates can be especially high for ischemic HF patients presenting with FMR and LVSD, but PCI may offer some relief. 
READ MORE >

AI models capable of identifying RV, LV dysfunction in ECGs

Specialists used EHR data, imaging results and natural language processing to bring their advanced AI models to life. 

READ MORE >
Electrocardiograms analyzed by AI can offer information about mortality risk.
Share on Twitter Share on Facebook Share on Linkedin

AI models capable of identifying RV, LV dysfunction in ECGs

Share on Twitter Share on Facebook Share on Linkedin
Electrocardiograms analyzed by AI can offer information about mortality risk.
Specialists used EHR data, imaging results and natural language processing to bring their advanced AI models to life. 
READ MORE >

Pfizer finalizes $6.7 billion acquisition of Arena Pharmaceuticals, gaining key cardiovascular treatments

Etrasimod, an oral medication developed to treat certain inflammatory conditions, was at the center of Pfizer’s acquisition, but some key cardiovascular assets were also part of the transaction. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Pfizer finalizes $6.7 billion acquisition of Arena Pharmaceuticals, gaining key cardiovascular treatments

Share on Twitter Share on Facebook Share on Linkedin
Etrasimod, an oral medication developed to treat certain inflammatory conditions, was at the center of Pfizer’s acquisition, but some key cardiovascular assets were also part of the transaction. 
READ MORE >

AI-powered ECG analysis could boost care for patients with hypertrophic cardiomyopathy

Advanced algorithms can pick up on key details in a 12-lead ECG that human readers are unable to see. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

AI-powered ECG analysis could boost care for patients with hypertrophic cardiomyopathy

Share on Twitter Share on Facebook Share on Linkedin
Advanced algorithms can pick up on key details in a 12-lead ECG that human readers are unable to see. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme